Quick Answer
Tiziana Life Sciences Ltd reported R&D Expense of $5.23 million for fiscal year 2024.
Tiziana Life Sciences Ltd R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $5.23M | -35.5% |
| 2023 | $8.11M | -37.4% |
| 2022 | $12.96M | -1.9% |
| 2021 | $13.21M | +120.4% |
| 2020 | $5.99M | +61.4% |
| 2019 | $3.71M | -32.6% |
| 2018 | $5.51M | -8.4% |
| 2017 | $6.01M | +50.1% |
| 2016 | $4.01M | — |
- Tiziana Life Sciences Ltd showed a decrease of -35.5% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2024 period, Tiziana Life Sciences Ltd’s r&d expense has grown by 30.5% (from $4.01 million to $5.23 million).
- The most recent figure is from Tiziana Life Sciences Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 6, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: